Tackling the Bone with Alpha Emitters in Metastatic Castration-resistant Prostate Cancer Patients

被引:9
作者
Bellmunt, Joaquim [1 ]
机构
[1] Pompeu Fabra Univ, Univ Hosp del Mar IMIM, Dept Oncol, Barcelona 08003, Spain
关键词
PHASE-II; RADIUM-223; MITOXANTRONE; MULTICENTER; PALLIATION; PREDNISONE;
D O I
10.1016/j.eururo.2012.09.062
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
引用
收藏
页码:198 / 200
页数:3
相关论文
共 12 条
[1]
Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[2]
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[3]
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases [J].
Goyal, Jatinder ;
Antonarakis, Emmanuel S. .
CANCER LETTERS, 2012, 323 (02) :135-146
[4]
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. [J].
Kantoff, Philip W. ;
Higano, Celestia S. ;
Shore, Neal D. ;
Berger, E. Roy ;
Small, Eric J. ;
Penson, David F. ;
Redfern, Charles H. ;
Ferrari, Anna C. ;
Dreicer, Robert ;
Sims, Robert B. ;
Xu, Yi ;
Frohlich, Mark W. ;
Schellhammer, Paul F. ;
Ahmed, T. ;
Amin, A. ;
Arseneau, J. ;
Barth, N. ;
Bernstein, G. ;
Bracken, B. ;
Burch, P. ;
Caggiano, V. ;
Chin, J. ;
Chodak, G. ;
Chu, F. ;
Corman, J. ;
Curti, B. ;
Dawson, N. ;
Deeken, J. F. ;
Dubernet, T. ;
Fishman, M. ;
Flanigan, R. ;
Gailani, F. ;
Garbo, L. ;
Gardner, T. ;
Gelmann, E. ;
George, D. ;
Godfrey, T. ;
Gomella, L. ;
Guerra, M. ;
Hall, S. ;
Hanson, J. ;
Israeli, R. ;
Jancis, E. ;
Jewett, M. A. S. ;
Kassabian, V. ;
Katz, J. ;
Klotz, L. ;
Koeneman, K. ;
Koh, H. ;
Kratzke, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) :411-422
[5]
Radiation-based approaches for therapy and palliation of advanced prostate cancer [J].
Lewis, Brian ;
Sartor, Oliver .
CURRENT OPINION IN UROLOGY, 2012, 22 (03) :183-189
[6]
First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases [J].
Nilsson, S ;
Larsen, RH ;
Fosså, SD ;
Balteskard, L ;
Borch, KW ;
Westlin, JE ;
Salberg, G ;
Bruland, OS .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4451-4459
[7]
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer [J].
Nilsson, S. ;
Strang, P. ;
Aksnes, A. K. ;
Franzen, L. ;
Olivier, P. ;
Pecking, A. ;
Staffurth, J. ;
Vasanthan, S. ;
Andersson, C. ;
Bruland, O. S. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (05) :678-686
[8]
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer:: a randomised, multicentre, placebo-controlled phase II study [J].
Nilsson, Sten ;
Franzen, Lars ;
Parker, Christopher ;
Tyrrell, Christopher ;
Blom, Rene ;
Tennvall, Jan ;
Lennernas, Bo ;
Petersson, Ulf ;
Johannessen, Dag C. ;
Sokal, Michael ;
Pigott, Katharine ;
Yachnin, Jeffrey ;
Garkavij, Michael ;
Strang, Peter ;
Harmenberg, Johan ;
Bolstad, Bjorg ;
Bruland, Oyvind S. .
LANCET ONCOLOGY, 2007, 8 (07) :587-594
[9]
Parker C., 2012, Journal of Clinical Oncology, V30
[10]
A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer [J].
Parker, Christopher C. ;
Pascoe, Sarah ;
Chodacki, Ales ;
O'Sullivan, Joe M. ;
Germa, Josep R. ;
O'Bryan-Tear, Charles Gillies ;
Haider, Trond ;
Hoskin, Peter .
EUROPEAN UROLOGY, 2013, 63 (02) :189-197